Rabu, 12 Desember 2018
CArisk - Prodia Genomic Testing to Identify Your Genetic Cancer Risk
What is CArisk?
CArisk is a genomic test that screens for 8 (eight) of the most common cancer type through analyzing 64 different genes using the microarray platform.
CArisk, help you to:
- Develop a treatment plan that is likely to reduce cancer risk in individuals who test positive.
- Design a personalized cancer screening program, tailored to individual risk
- Provide information for adults, as well as children as they become adults.
- Making decisions for Deciding for CArisk, as a personal choice if your family has a history of cancer or as a preventive and predictive action for an overall improved health.
CArisk can help to predict your risk for cancer:
- Lung cancer
- Pancreatic cancer
- Breast cancer
- Colorectal cancer
- Cervical cancer
- Liver cancer
- Gastric cancer
- Uterine fibroid
What CArisk informs you:
- Your Genotype-related Cancer Risks
- Suggested tests if you are at high risk
Your DNA can determine your risk for cancer. Based on your genetic results, the risks will be classified into:
What should I do if the result “high risk”?
- Don’t worry, it is not a diagnosis!
- It means that you have to be screened early or more frequently so cancer can be detected early. Early detection of cancer increases the chances of successful treatment and survival rate.
- Individuals with a higher rik of cancer can benefit from taking FDA-approved drugs to lower the chance of developing certain cancers.
- You can improve your life style because gene expressions are influenced by the environment, your diet, as well as your exercise regimen.
*Genetic counselor available with an appointment
The advantages of CArisk by Prodia
- High Quality. Experienced in advance lab testing since 1973 with international standards.
- Provided locally with excellence by the nation’s Prodia Genomics Lab located in Jakarta, Indonesia.
- Nationwide coverage (286 Outlets all over Indonesia). Anyone, anywhere, Prodia is reachable.